← Back

Wire · opportunities

FDA Seeks Public Feedback on Regulatory Approach for Generative AI-Enabled Medical Devices

Published

2 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at arnoldporter.com →

◆ Verified

Fusion42 · 2 September 2026 · Fusion42 review

The FDA's Center for Devices and Radiological Health is seeking public feedback on a regulatory framework for generative AI-enabled medical devices, addressing risk assessment, premarket evaluation, and postmarket monitoring specific to the unique challenges these devices present.

This Wire brief sits within Fusion42's coverage of Medtech, and 19 sources have reported it between 18 Aug 2026 and 18 Sep 2026.

◆ ◆ The Wire takeaway

You face a fresh regulatory frontier as the FDA plans a balanced premarket and postmarket approach specifically for generative AI in medical devices. Start aligning your development and compliance roadmaps to navigate evolving data and evidence requirements now.

◆ Coverage

19 sources · first reported 18 Aug 2026 · latest 18 Sep 2026

◆ Related on Wire

◆ Topics

Medtechfdaregulationgenerative-aimedical-devicesdigital-health